Paul C Grint - Net Worth and Insider Trading

Paul C Grint Net Worth

The estimated net worth of Paul C Grint is at least $464,226 dollars as of 2024-05-12. Paul C Grint is the Director of Illumina Inc and owns about 4,200 shares of Illumina Inc (ILMN) stock worth over $464,226. Details can be seen in Paul C Grint's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul C Grint has not made any transactions after 2010-10-27 and currently still holds the listed stock(s).

Transaction Summary of Paul C Grint

To

Paul C Grint Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul C Grint owns 4 companies in total, including Armata Pharmaceuticals Inc (ARMP) , Regulus Therapeutics Inc (RGLS) , and Illumina Inc (ILMN) among others .

Click here to see the complete history of Paul C Grint’s form 4 insider trades.

Insider Ownership Summary of Paul C Grint

Ticker Comapny Transaction Date Type of Owner
ARMP Armata Pharmaceuticals Inc 2015-11-05 director
RGLS Regulus Therapeutics Inc 2014-06-16 Chief Medical Officer
ILMN Illumina Inc 2010-10-27 director
2023-06-30 director

Paul C Grint Latest Holdings Summary

Paul C Grint currently owns a total of 1 stock. Paul C Grint owns 4,200 shares of Illumina Inc (ILMN) as of October 27, 2010, with a value of $464,226.

Latest Holdings of Paul C Grint

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ILMN Illumina Inc 2010-10-27 4,200 110.53 464,226

Holding Weightings of Paul C Grint


Paul C Grint Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul C Grint has made a total of 0 transactions in Illumina Inc (ILMN) over the past 5 years. The most-recent trade in Illumina Inc is the sale of 10,000 shares on October 27, 2010, which brought Paul C Grint around $558,100.

Insider Trading History of Paul C Grint

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul C Grint Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul C Grint Ownership Network

Ownership Network List of Paul C Grint

No Data

Ownership Network Relation of Paul C Grint


Paul C Grint Owned Company Details

What does Armata Pharmaceuticals Inc do?

Who are the key executives at Armata Pharmaceuticals Inc?

Paul C Grint is the director of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .

Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Armata Pharmaceuticals Inc Insider Transactions

No Available Data

Paul C Grint Mailing Address

Above is the net worth, insider trading, and ownership report for Paul C Grint. You might contact Paul C Grint via mailing address: 7757 Doughill Court, San Diego Ca 92127.

Discussions on Paul C Grint

No discussions yet.